Federal documents show he disagreed with conclusions the benefits outweighed the risk of side effects, which are rare.

The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...

The virus has not yet evolved to spread efficiently between people. Excellent vaccine technology exists, but the government ...

The top shareholders of Moderna are Stéphane Bancel, Noubar B. Afeyan, Stephen Hoge, Baillie Gifford & Co., Vanguard Group Inc., and BlackRock Inc.

Moderna MRNA announced the FDA approval for mRNA-1283, its next-generation refrigerator-stable COVID-19 vaccine, though for a label narrower than initially targeted. The vaccine will be marketed ...

Moderna Inc. gained US approval for a new Covid vaccine for a narrower group of people, in the latest sign that regulators are restricting access to immunizations under the leadership of Health ...

Moderna's mRNA-based flu vaccine funding is cancelled by the Department of Health and Human Services, arguing lack of scientific and ethical justification.

Moderna's (MRNA) stock rose more than 3% in trading on Thursday despite an announcement that the National Institutes of Health (NIH), led by Robert F. Kennedy Jr., is ending a $750 million-plus ...

Moderna, the biotech company behind one of the original mRNA COVID-19 vaccines, is undergoing an AI-powered workplace transformation. In partnership with OpenAI, Moderna has created thousands of ...

Now let's consider where Moderna will be a few years from now. The company recently said it aims to bring as many as 10 products to market by 2027. So in five years, if all goes well in clinical ...